WASHINGTON, Oct. 31,
2024 /PRNewswire/ -- US Biologic, Inc., Global Lyme
Alliance (GLA), and the Center for Lyme Action (CLA) celebrate
today the passage of Delaware
HB404 bill, "AN ACT TO AMEND TITLE 3 OF THE DELAWARE CODE RELATING TO LYME DISEASE" (bill
detail), which creates a Lyme and tickborne disease intervention
fund overseen by the Department of Agriculture and "shall have the
goal of reducing the prevalence of Lyme disease and potential for
contracting Lyme disease on State owned lands." Further, the bill
instructs the Department of Agriculture to "administer the fund
with the goal of reducing the prevalence of Lyme disease, other
tick-borne illnesses, and the animals known to carry Lyme disease
and other tick-borne illnesses on State-owned lands in places
people are likely to contract the disease."
The bill, signed by Governor John
Carney on October 23, 2024,
was first introduced by Representative William J. Carson (DE House District 28) and,
upon unanimous bipartisan approval by the Delaware House of Representatives, was
introduced into the Delaware State Senate by Senator Kyle Evans Gay (Senate District 5), where it
received similar unanimous bipartisan approval.
"Lyme is the number one vector-borne disease," says Chris Przybyszewski, US Biologic President.
"This bill by Representative Carson and Senator Gay, and as signed
by Governor Carney, creates a tangible statewide commitment to
fight back." Przybyszewski notes that while human-based diagnostics
and treatments are essential, "we must also address wildlife
sources, primarily the transmission between white-footed mice and
ticks. This aspect of the bill is critically important."
Paul Ross, GLA Chairman, echoes
this sentiment: "It's crucial that we continue to expand resources
to combat Lyme and other tick-borne diseases. Delaware's commitment to these efforts is
commendable and should be celebrated by the entire community."
"This is important leadership by Delaware and especially Delaware Lyme
advocates, and it provides a roadmap for additional states to
follow," says Bonnie Crater,
co-founder and board director of Center for Lyme Action. "We join
US Biologic and GLA in commemorating this historic
legislation."
About US Biologic, Inc.
US Biologic, Inc. (www.usbiologic.com) "delivers disease
prevention" by developing oral, thermostable, multi-species
vaccines and biologics to fight the world's greatest animal health
and public health threats. We prioritize global collaboration,
health equity, transparency, practical solutions, and a strong
business plan. We are the creators of the LymeShield System
(www.lymeshield.com), a revolutionary integrated tick-management
program to fight Lyme Disease. US Biologic: Aspire.
Innovate. Deliver.
About the Global Lyme Alliance
The Global Lyme Alliance (www.globallymealliance.org) is the
leading nonprofit dedicated to conquering Lyme and other tick-borne
diseases. Our Mission: Cure Lyme and other tick-borne diseases
through innovative research, awareness, and empowering the patient
voice. Our vision: A world free of Lyme and other tick-borne
diseases.
About the Center for Lyme Action
The Center for Lyme Action (https://centerforlymeaction.org) is
a 501c4 dedicated to growing federal funding for Lyme and tickborne
conditions in an effort to find cures — especially for Lyme
patients with persistent, debilitating symptoms.
Media Contact:
Chris Przybyszewski, President
US Biologic, Inc.
chris.przybyszewski@usbiologic.com
901-490-5857
View original content to download
multimedia:https://www.prnewswire.com/news-releases/us-biologic-global-lyme-alliance-and-center-for-lyme-action-celebrate-passage-of-delaware-bill-to-fight-ticks-at-the-animal-source-302293573.html
SOURCE Center for Lyme Action